Biobanking Science: Brainstorm Consortium Finds Genetic Link for Brain Diseases
One of the major benefits of biobanking is the ability to safely collect and store large numbers of biological samples. This allows researchers to generate large datasets to study the genetic cause of various diseases. The Brainstorm Consortium uses...
Biobanking Science: Lessons from African Biobanks
With the recent advances in genomic sequencing, proteomics and precision medicine, biobanks are becoming more prevalent around the world. So are large-scale population studies such as the UK Biobank.
H3Africa Project and Biobanks
The Human, Hereditary and Health in Africa (H3Africa)...
A2LA Accredits First Human Biobank to ISO 20387
April 3, 2020, Frederick, MD – A2LA is pleased to announce the accreditation of Forever Labs, located in Michigan, to ISO 20387:2018 for human biobanking activities. Forever Labs is the first human biobank in the United States to be...
Biobanking Science: Cancer Biobanks
Cancer is major cause of death worldwide and mortality levels remain high despite the development of new therapeutics and other cancer treatments. Cancer biobanks are an integral part of the fight against cancer because they facilitate research into new...
Brooks Automation, Inc. has acquired BioSpeciMan Corporation Biorepository
Brooks Automation, Inc. (Nasdaq: BRKS) is a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences. Brooks' technologies, engineering competencies and global service capabilities provide customers speed to market and ensure...
‘Human Emulation System’ as a Platform for Drug Discovery – Partnership with Roche
The ‘Human Emulation System’ is an organ-on-chip technology developed by Emulate, Inc. The chips are made from transparent polymers and are about the size of an AA battery, though they are flat. They contain microfluidic channels that can be...
Regeneron Confirms New Chronic Liver Disease Drug Target Using Biobank Data
For the first time Regeneron has reported a variant in the HSD17B13 gene that is associated with reduced risk of, in other words protection from, various chronic liver diseases for which there are currently no approved therapeutics . The...
AmnioFix® Injectable Granted RMAT Designation By The FDA For The Treatment Of Osteoarthritis Of...
MiMedx Group, Inc. developed the proprietary PURION® Process that separates placental tissues collected after birth, cleans and reassembles layers, and then dehydrates the tissue for long term storage under sterile conditions. The PURION® Process removes free blood while retaining...
BC Platforms And IQVIA To Launch New Data Driven Technologies
BC Platforms, a world leader in genomic data management and
analytics, has closed a USD $15 million financing round alongside a new
commercial collaboration with IQVIA™. The round was led by IQVIA in conjunction
with Debiopharm Innovation Fund and Tesi, a Finnish...
Biobanking Science: New Non-Toxic Cryoprotectant Solutions
Cell therapy is a rapidly growing field that uses live cells to treat patients. This presents unique biobanking challenges because, unlike traditional pharmaceutical products, cells must be alive and functional to be effective therapeutics. Unless cell therapy cells are...
